In clinical research, biological sex has long been treated as a simple demographic variable. However, a growing body of evidence suggests that sex—specifically the presence and fluctuation of sex hormones—acts as a fundamental "filter" that changes how the body translates systemic stress into physical disease.
Whether it is the protective effect of estrogen against arterial aging or the way testosterone mediates the risk of tumors in women, sex hormones do not just change the prevalence of diseases; they change the biological mechanisms through which those diseases develop.
The Hormonal Filter of Inflammation
The most striking pattern across recent studies is that the same level of systemic inflammation can lead to vastly different clinical outcomes depending on a patient's hormonal profile. Researchers often use composite markers like the Systemic Immune-Inflammation Index (SII) or the Monocyte-to-Lymphocyte Ratio (MLR) to predict disease. While these markers are highly effective in men, they often lose their predictive power in women.
For example, Yaolin Wang and colleagues found that the MLR effectively predicts arterial stiffness in men, but is less reliable in women. The intuition here is that estrogen acts as a natural anti-inflammatory buffer. It may "mask" the vascular damage that would otherwise be caused by high leukocyte counts. Similarly, Yan Zhou demonstrated that the Advanced Lung Cancer Inflammation Index (ALI) is a potent predictor of kidney stone risk in men, but has limited utility for women, likely because hormonal factors fundamentally alter the physiological pathways leading to stone formation.
This suggests that for women, inflammation may need to cross a higher "threshold" or follow a non-linear path before it manifests as tissue damage. Chengjun Li observed this non-linearity in cardiovascular disease, where the relationship between inflammatory markers and risk can shift from a steady progression to a sudden "tipping point."
Life Transitions as Mechanistic Shifts
If hormones modulate disease, then the periods when those hormones change—puberty and menopause—should coincide with shifts in disease trajectory. The data confirms this "sex shift."
In a meta-analysis of five birth cohorts, Cynthia Hohmann and Theresa Keller showed that while boys are more prone to asthma and rhinitis in childhood, the risk balances out or even flips toward girls after puberty onset. This implies that the surge of estrogen or androgens during adolescence reconfigures the airway's inflammatory response.
A similar phenomenon occurs later in life. Xinnian Yang and Jiayin Zhang identified a 20-year delay in the onset of coronary atherosclerosis in women compared to men. However, this protection isn't permanent; female plaque progression shows a non-linear acceleration that coincides with menopause. This suggests that the loss of estrogen doesn't just stop a protective process—it may trigger a rapid "catch-up" phase of inflammatory damage.
Divergent Pathways to the Same Pathology
Perhaps the most compelling evidence for sex-specific mechanisms is when the cause of a disease differs entirely between sexes.
In the study of adrenal tumors, Qiwei Wang and Dingyang Lv used Mendelian Randomization to show that while obesity is a causal risk factor for both sexes, the mediating mechanism in women is specifically driven by elevated testosterone levels. In men, this testosterone-mediated pathway was not observed.
This divergence extends to the molecular level. In psoriasis research, Xin Yang and Bibo Xie found that estrogen signaling pathways produce different inflammatory outcomes in male versus female skin tissue. Even when the same hormonal signal is present, the "downstream" proteomic response is sex-context dependent.
Implications for Precision Medicine
The recurring theme across these 14 papers is that "unisex" diagnostic tools and risk models are inherently limited. When Martin C. S. Wong found that high BMI increases colorectal adenoma risk more significantly in women than in men, it pointed toward a need for sex-adjusted screening guidelines.
To move toward true precision medicine, researchers like Vijay Shyam-Sundar and Nay Aung argue for sex-specific diagnostic considerations in conditions like myocarditis, where the age of onset and severity of tissue damage follow distinct, sex-based patterns. Understanding why these differences exist—whether through estrogen's hippocampal activation in migraines (Biao Huang) or myeloid-driven cytokine storms in IBD (Chengyan Zhang)—is the necessary next step in developing treatments that work for all patients.